GlycoMimetics, Inc. (GLYC)
NASDAQ: GLYC · Real-Time Price · USD
0.318
-0.012 (-3.73%)
Nov 21, 2024, 2:39 PM EST - Market open

GlycoMimetics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Revenue
0.010.010.081.1610.16-
Upgrade
Revenue Growth (YoY)
--86.67%-93.53%-88.59%--
Upgrade
Gross Profit
0.010.010.081.1610.16-
Upgrade
Selling, General & Admin
17.4819.2119.0917.1216.7414.36
Upgrade
Research & Development
19.3120.0728.3947.4944.9347.03
Upgrade
Operating Expenses
36.7939.2947.4864.6161.6761.39
Upgrade
Operating Income
-36.78-39.28-47.4-63.45-51.51-61.39
Upgrade
Interest & Investment Income
1.342.380.710.020.483.5
Upgrade
Pretax Income
-39.74-36.9-46.69-63.43-51.03-57.89
Upgrade
Net Income
-39.74-36.9-46.69-63.43-51.03-57.89
Upgrade
Net Income to Common
-39.74-36.9-46.69-63.43-51.03-57.89
Upgrade
Shares Outstanding (Basic)
646353514643
Upgrade
Shares Outstanding (Diluted)
646353514643
Upgrade
Shares Change (YoY)
6.56%20.58%2.10%12.54%5.70%5.38%
Upgrade
EPS (Basic)
-0.62-0.58-0.89-1.23-1.12-1.34
Upgrade
EPS (Diluted)
-0.62-0.58-0.89-1.23-1.12-1.34
Upgrade
Free Cash Flow
-35.02-34.9-46.54-57.5-39.31-52.13
Upgrade
Free Cash Flow Per Share
-0.54-0.55-0.89-1.12-0.86-1.21
Upgrade
Gross Margin
100.00%100.00%100.00%100.00%100.00%-
Upgrade
Operating Margin
-367847.59%-392752.93%-63204.43%-5470.69%-506.84%-
Upgrade
Profit Margin
-397350.46%-368994.20%-62251.74%-5468.98%-502.09%-
Upgrade
Free Cash Flow Margin
-350223.62%-349012.97%-62055.57%-4958.28%-386.80%-
Upgrade
EBITDA
-36.73-39.12-47.2-63.18-51.24-61.11
Upgrade
D&A For EBITDA
0.060.150.210.260.270.28
Upgrade
EBIT
-36.78-39.28-47.4-63.45-51.51-61.39
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.